2018 May 9

Read the last issue of IDSA News

Read the next issue of IDSA News

In Memoriam

Stanley Falkow, PhD, FIDSA, passed away on Saturday, May 5, 2018 at his home in Portola Valley, California.

Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Reviews in this issue: Mortality Benefit in Treating HCV-Infected Patients Without Advanced Liver Disease, Aerosolized and Oral Ribavirin for Respiratory Syncytial Virus Infection, and Back to the Basics: Hospital-Acquired Infections and Exposure to Other Sick Patients

Paper, Plastic, Digital: Join Us for a Discussion on
the Future of IDSA Journals

In response to a member discussion on MyIDSA regarding IDSA’s journals, the use of plastic wrap and interest in an online-only option, IDSA will be holding a webinar May 15 at 4 p.m. EDT to discuss how we can work together to meet the needs of the Society and our members, while also protecting our natural resources.

How is Tech Used in ID Clinical Practice? Work Group Launches Member Survey

The IDSA Telehealth and Emerging Technology Work Group has prepared a survey for our members to gain a better understanding of how telehealth technology is being used in the clinical practice of infectious diseases.

Encourage Your Fellows to Compete in IDBugBowl 2018!

Are fellows at your institution interested in competing in the IDBugBowl? Well, this is their chance! Forward the link below so that they can apply for your institution to be one of the two national teams going up against two San Francisco teams at IDWeek 2018.

New Public Health Emergency Preparedness Bill
in the Senate

IDSA is continuing to advance our priorities as Congress moves forward on efforts to reauthorize the Pandemic and All Hazards Preparedness Act (PAHPA).

Vectorborne Disease Updates

The Centers for Disease Control and Prevention (CDC) released their newest Morbidity and Mortality Weekly Report last week entitled “Vital Signs: Trends in Reported Vectorborne Disease Cases- United States and Territories, 2004-2016.”

Now Hear This: OFID Podcasts on iTunes

Interested in engaging conversations related to the ID field? Open Forum Infectious Diseases (OFID) podcasts are now available on iTunes.

US Investments in Global Health Technologies: Educating Congress About the Value

IDSA member, James Crowe, MD, FIDSA of Vanderbilt University spoke to Congressional staffers last week about the impact of US investments on the development of global health technologies and the returns on those investments.

Science Speaks

IDSA’s Science Speaks blog discussed the global health considerations facing new Secretary of State Mike Pompeo and covered reports on the small world of international infectious disease responses.

Does 340B Make a Difference in Your HIV or ID Program?

Share examples from your clinic or institution that will help us demonstrate to policymakers the implications of changes to the 340B Drug Discount Program.

Leading Advocacy Efforts to Preserve Access to
In Vitro Diagnostics

The current draft of the Diagnostic Accuracy and Innovation Act (DAIA) contains prohibitive regulatory and budgetary implications for laboratory developed tests and threatens to wipe out many of the tests ID physicians use to manage some of the most seriously ill patients.